Intra Dialytic Parenteral Nutrition and Nutritional Gap Nutritional Gap Identified by Indirect Calorimetry (DiaPaNIC)
Primary Purpose
Chronic Kidney Diseases, Protein Energy Wasting
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Indirect Calorimetry
Bio-electrical Impedance Analysis (BIA)
Nutritional assessments
Sponsored by
About this trial
This is an interventional supportive care trial for Chronic Kidney Diseases focused on measuring Indirect Calorimetry, Parenteral Nutrition, Hemodialysis
Eligibility Criteria
Inclusion Criteria:
- Patient on intermittent hemodialysis
- Protein-Energy Wasting defined as 5% within 3 months or 10% within 6 months (not due to water loss, established at the discretion of the treating physician)
Exclusion Criteria:
- Pregnancy
- Contra-indications for the use of indirect calorimetry as stated by the AARC (oxygen therapy for COPD,...)
- Metabolic diseases
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Assessments
Arm Description
In this single-arm trial, each participant undergoes the following measurements/assessments: Physical: Body weight (before and after dialysis), length Biophysical: NRS2002, GLIM, Bio-electrical Impedance Analysis Metabolic: Indirect Calorimetry Nutritional: dietary anamnesis, 3-days nutritional diary
Outcomes
Primary Outcome Measures
Caloric adequacy
caloric intake (kcal/day) and caloric need (kcal/day) (see secondary outcomes) will be combined to report caloric adequacy according to this equation: [sum of percentage of caloric intake/caloric need]/total of evaluable nutrition days (%)
Secondary Outcome Measures
Protein adequacy
protein intake (from nutritional assessments)/protein need (%)
Fat Mass (FM)
measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
Fat Free Mass (FFM)
measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
Phase angle
measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
Body weight
Body weight (kg)
Compatibility between the caloric gap and PN ready to use formulae on the market
Comparison between individual caloric need of patients and ready to use PN formulae (PeriOlimel N4E (Baxter), Olimel N5E (Baxter), Olimel N7E (Baxter), Olimel N9/N9E (Baxter), Olimel N12/N12E (Baxter), SMOFKabiven Ex-tra Amino (Fresenius), SMOFKabiven peripheral (Fresenius), SMOFKabiven Peri Low Osmo (Fresenius), SMOFKabiven E/EF (Frese-nius), Omegomel Peri (Baxter), Nutriflex Omega Special (B Braun); based on caloric content per bag of PN on the market (Unit of measurement: portion of PN bag (%) needed to close the caloric gap)
Mean caloric intake
(kcal/day) from nutritional assessments (3-day nutritional diary and nutritional anamnesis
Caloric need
(kcal/day): Resting Energy Expenditure (REE) measured by Indirect Calorimetry (IC)
Mean protein intake
g/day): from nutritional assessments (3-day nutritional diary and nutritional anamnesis
Barriers for patients for use of IDPN
"would you agree to IDPN if your health condition required it? Please elaborate"
Barriers for dialysis nurses and nephrologists for use of IDPN
"Are logistical and practical barriers holding you back from prescribing or administering IDPV? Please elaborate."
Full Information
NCT ID
NCT05568914
First Posted
August 30, 2022
Last Updated
June 2, 2023
Sponsor
Universitair Ziekenhuis Brussel
Collaborators
Baxter Healthcare Corporation
1. Study Identification
Unique Protocol Identification Number
NCT05568914
Brief Title
Intra Dialytic Parenteral Nutrition and Nutritional Gap Nutritional Gap Identified by Indirect Calorimetry
Acronym
DiaPaNIC
Official Title
Intra Dialytic Parenteral Nutrition During Intermittent Hemodialysis Can Close the Nutritional Gap Identified by Indirect Calorimetry: a Pilot and Feasibility Study
Study Type
Interventional
2. Study Status
Record Verification Date
July 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 1, 2023 (Anticipated)
Primary Completion Date
August 31, 2024 (Anticipated)
Study Completion Date
August 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universitair Ziekenhuis Brussel
Collaborators
Baxter Healthcare Corporation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Renal failure is a relevant condition as the incidence of patients treated with intermittent dialysis continues to grow each year. One of the strongest predictors of mortality in these patients is Protein-Energy Wasting (PEW). Optimal nutritional support, combined with physical exercise may be able to improve the physical condition objectified as muscle wasting and weakness. Correct nutritional support must aim to supplement the correct combination of protein and caloric needs. Although no other way exist than predicting formula to assess protein need, predicting formula don't seem to capture the individual caloric need of the patients. The gold standard to assess caloric need by measuring Resting Energy Expenditure (REE) is indirect calorimetry. Even when caloric and protein targets are defined, intake remains a challenge because of intake restriction in dietary patterns. This is why intradialytic parenteral nutrition (IDPN) can play an crucial role for closing the nutritional gap. Whether IDPN guided by indirect calorimetric measurements of metabolism can close the gap when oral intake fails, remains an unanswered question.
Detailed Description
Renal failure is a relevant condition as the incidence of patients treated with renal replacement therapy and specifically intermittent dialysis, continues to grow each year. In 2021 up to 4845 patients required intermittent dialysis in Flanders, Belgium. Weight loss and homeostatic disturbances of energy and protein balances are often present in Chronic Kidney disease (CKD) and end-stage renal disease (ESRD).The international society of renal nutrition and metabolism defines Protein-Energy Wasting (PEW) as the state of nutritional and metabolic disorders in patients with CKD and ESRD, characterized by simultaneous loss of systemic body protein and energy stores. PEW is one of the strongest predictors of mortality in CKD patients. Up tot 54% of adults undergoing chronic intermittent haemodialysis (IHD) suffer from PEW due to a combination of the disease and therapy. Adequate nutritional therapy can reverse the negative impact of PEW. Optimal nutritional support, next to physical exercise may be able to improve the physical condition objectified as muscle wasting and weakness. Correct nutritional support must aim to supplement the correct combination of protein and caloric after assessing the needs and intake of different nutrients. Although no other way exist than predicting formula to assess protein need, predicting formula don't seem to capture the individual caloric need of the patients. The gold standard to assess caloric need by measuring Resting Energy Expenditure (REE) is indirect calorimetry. This technique measures the individual VCO2 and VO2 and after integrating it into the Weir equation it calculates REE. Even when caloric and protein target are defined, intake remains a challenge because of intake restriction in dietary patterns. This is why intradialytic parenteral nutrition (IDPN) can play an crucial role for closing the nutritional gap. In clinical practice, in 38% of dialysis patients, IDPN is used. The most common IDPN were triple phase bags. Whether IDPN guided by indirect calorimetric measurements of metabolism can close the gap when oral intake fails, remains an unanswered question.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Diseases, Protein Energy Wasting
Keywords
Indirect Calorimetry, Parenteral Nutrition, Hemodialysis
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Assessments
Arm Type
Experimental
Arm Description
In this single-arm trial, each participant undergoes the following measurements/assessments:
Physical: Body weight (before and after dialysis), length Biophysical: NRS2002, GLIM, Bio-electrical Impedance Analysis Metabolic: Indirect Calorimetry Nutritional: dietary anamnesis, 3-days nutritional diary
Intervention Type
Device
Intervention Name(s)
Indirect Calorimetry
Other Intervention Name(s)
Q-NRG Metabolic Monitor, COSMED
Intervention Description
Indirect Calorimetry (Q-NRG Metabolic Monitor, COSMED) is performed to determine the Resting Energy Expenditure before hemodialysis.
Intervention Type
Device
Intervention Name(s)
Bio-electrical Impedance Analysis (BIA)
Other Intervention Name(s)
BIA101/BIVA, Akern
Intervention Description
Bio-electrical Impedance Analysis (BIA101/BIVA, Akern) is used to analyse the body composition (Fat Mass, Fat Free Mass, Phase Angle).
Intervention Type
Other
Intervention Name(s)
Nutritional assessments
Other Intervention Name(s)
Dietary anamnesis, Nutritional diary
Intervention Description
The Nutritional assessments consist of a dietary anamnesis and a 3-day nutritional diary to determine the nutritional (caloric and protein) intake of the participants.
Primary Outcome Measure Information:
Title
Caloric adequacy
Description
caloric intake (kcal/day) and caloric need (kcal/day) (see secondary outcomes) will be combined to report caloric adequacy according to this equation: [sum of percentage of caloric intake/caloric need]/total of evaluable nutrition days (%)
Time Frame
Pre-dialysis
Secondary Outcome Measure Information:
Title
Protein adequacy
Description
protein intake (from nutritional assessments)/protein need (%)
Time Frame
Pre-dialysis
Title
Fat Mass (FM)
Description
measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
Time Frame
20-30 minutes after dialysis
Title
Fat Free Mass (FFM)
Description
measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
Time Frame
20-30 minutes after dialysis
Title
Phase angle
Description
measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
Time Frame
20-30 minutes after dialysis
Title
Body weight
Description
Body weight (kg)
Time Frame
before and after hemodialysis
Title
Compatibility between the caloric gap and PN ready to use formulae on the market
Description
Comparison between individual caloric need of patients and ready to use PN formulae (PeriOlimel N4E (Baxter), Olimel N5E (Baxter), Olimel N7E (Baxter), Olimel N9/N9E (Baxter), Olimel N12/N12E (Baxter), SMOFKabiven Ex-tra Amino (Fresenius), SMOFKabiven peripheral (Fresenius), SMOFKabiven Peri Low Osmo (Fresenius), SMOFKabiven E/EF (Frese-nius), Omegomel Peri (Baxter), Nutriflex Omega Special (B Braun); based on caloric content per bag of PN on the market (Unit of measurement: portion of PN bag (%) needed to close the caloric gap)
Time Frame
through study completion or one year, whichever is sooner
Title
Mean caloric intake
Description
(kcal/day) from nutritional assessments (3-day nutritional diary and nutritional anamnesis
Time Frame
pre-dialysis
Title
Caloric need
Description
(kcal/day): Resting Energy Expenditure (REE) measured by Indirect Calorimetry (IC)
Time Frame
pre-dialysis
Title
Mean protein intake
Description
g/day): from nutritional assessments (3-day nutritional diary and nutritional anamnesis
Time Frame
pre-dialysis
Title
Barriers for patients for use of IDPN
Description
"would you agree to IDPN if your health condition required it? Please elaborate"
Time Frame
pre-dialysis
Title
Barriers for dialysis nurses and nephrologists for use of IDPN
Description
"Are logistical and practical barriers holding you back from prescribing or administering IDPV? Please elaborate."
Time Frame
throughout the duration of the trial
Other Pre-specified Outcome Measures:
Title
Descriptive outcomes
Description
age, sex, category of kidney disease, comorbidities, dialysis vintage (years)
Time Frame
pre-dialysis
Title
Dialysis type
Description
(from medical file)
Time Frame
During dialysis
Title
Delta REE between predicting formula and indirect calorimetry
Description
Difference in energy need as calculated using standard formula and measured using IC
Time Frame
Pre-dialysis
Title
Vascular access type
Description
(from medical file)
Time Frame
during dialysis
Title
Dialysis blood flow rate
Description
(from medical file)
Time Frame
During dialysis
Title
Hemodialysis treatment adequacy (kt/V)
Description
(from medical file)
Time Frame
During dialysis
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient on intermittent hemodialysis
Protein-Energy Wasting defined as 5% within 3 months or 10% within 6 months (not due to water loss, established at the discretion of the treating physician)
Exclusion Criteria:
Pregnancy
Contra-indications for the use of indirect calorimetry as stated by the AARC (oxygen therapy for COPD,...)
Metabolic diseases
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Elisabeth De Waele, MD, PhD
Phone
+3224763354
Email
elisabeth.dewaele@uzbrussel.be
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elisabeth De Waele, MD, PhD
Organizational Affiliation
Universitair Ziekenhuis Brussel
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Intra Dialytic Parenteral Nutrition and Nutritional Gap Nutritional Gap Identified by Indirect Calorimetry
We'll reach out to this number within 24 hrs